An example of the recalled medication. (FDA)Heads up, consumers: A diabetes drug is facing recall because the medication contains excess levels of a cancer-causing agent, the U.S.
Food and Drug Administration (FDA) announced this week.Marksans Pharma Limited, a pharmaceutical company in India, announced an expanded recalled of its Metformin hydrochloride extended-release tablets, a drug used to help those who suffer from type 2 diabetes to lower their blood glucose levels.
The recall, which was initially announced in June, was expanded on Monday to include an additional 76 unexpired lots of the medication.“Marksans performed N-Nitrosodimethylamine (NDMA) testing of unexpired identified marketed lots and observed that NDMA content in some.